M28 Capital Management’s Rocket Pharmaceuticals RCKT Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $945K | Hold |
385,680
| – | – | 1.61% | 9 |
|
|
2025
Q1 | $2.57M | Hold |
385,680
| – | – | 3.53% | 5 |
|
|
2024
Q4 | $4.85M | Hold |
385,680
| – | – | 4.76% | 3 |
|
|
2024
Q3 | $7.12M | Hold |
385,680
| – | – | 7.83% | 3 |
|
|
2024
Q2 | $8.3M | Hold |
385,680
| – | – | 10.76% | 3 |
|
|
2024
Q1 | $10.4M | Sell |
385,680
-137,600
| -26% | -$3.71M | 7.68% | 4 |
|
|
2023
Q4 | $15.7M | Hold |
523,280
| – | – | 12.99% | 3 |
|
|
2023
Q3 | $10.7M | Sell |
523,280
-107,100
| -17% | -$2.19M | 12.3% | 3 |
|
|
2023
Q2 | $12.5M | Sell |
630,380
-91,700
| -13% | -$1.82M | 16.55% | 2 |
|
|
2023
Q1 | $12.4M | Hold |
722,080
| – | – | 13.99% | 2 |
|
|
2022
Q4 | $14.1M | Buy |
722,080
+56,200
| +8% | +$1.1M | 13.47% | 2 |
|
|
2022
Q3 | $10.6M | Sell |
665,880
-50,000
| -7% | -$798K | 11.09% | 3 |
|
|
2022
Q2 | $9.85M | Hold |
715,880
| – | – | 11.04% | 3 |
|
|
2022
Q1 | $11.4M | Buy |
715,880
+220,600
| +45% | +$3.5M | 10.44% | 3 |
|
|
2021
Q4 | $10.8M | Buy |
+495,280
| New | +$10.8M | 8.44% | 5 |
|